Ana Ramos-Gonzalez

Prof. Dr. Ana Ramos-Gonzalez


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2021 in American Journal of Neuroradiology
Verified
Journal Article
Closed access
PDF file
AMA. Mahammedi
A. Mahammedi
ARAna Ramos-Gonzalez
Ana Ramos-Gonzalez
NBNuria Bargallo
Nuria Bargallo
MGM. Gaskill
M. Gaskill
SKS. Kapur
S. Kapur
AVA. Vagal
A. Vagal
PURPOSE: Our aim was to study the association between abnormal findings on chest and brain imaging in patients with coronavirus disease 2019 (COVID-19) and neurologic symptoms. MATERIALS AND METHODS: In this retrospective, international multicenter study, we reviewed the electronic medical records and imaging of hospitalized patients with COVID-19 from March 3, 2020, to June 25, 2020. Our inclusion criteria were patients diagnosed with Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) infection with acute neurologic manifestations and available chest CT and brain imaging. The 5 lobes of the lungs were individually scored on a scale of 0–5 (0 corresponded to no involvement and 5 corresponded to >75% involvement). A CT lung severity score was determined as the sum of lung involvement, ranging from 0 (no involvement) to 25 (maximum involvement). RESULTS: A total of 135 patients met the inclusion criteria with 132 brain CT, 36 brain MR imaging, 7 MRA of the head and neck, and 135 chest CT studies. Compared with 86 (64%) patients without acute abnormal findings on neuroimaging, 49 (36%) patients with these findings had a significantly higher mean CT lung severity score (9.9 versus 5.8, P < .001). These patients were more likely to present with ischemic stroke (40 [82%] versus 11 [13%], P < .0001) and were more likely to have either ground-glass opacities or consolidation (46 [94%] versus 73 [84%], P = .01) in the lungs. A threshold of the CT lung severity score of >8 was found to be 74% sensitive and 65% specific for acute abnormal findings on neuroimaging. The neuroimaging hallmarks of these patients were acute ischemic infarct (28%), intracranial hemorrhage (10%) including microhemorrhages (19%), and leukoencephalopathy with and/or without restricted diffusion (11%). The predominant CT chest findings were peripheral ground-glass opacities with or without consolidation. CONCLUSIONS: The CT lung disease severity score may be predictive of acute abnormalities on neuroimaging in patients with COVID-19 with neurologic manifestations. This can be used as a predictive tool in patient management to improve clinical outcome.

28 March 2019 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
JPJulián Pérez-Beteta
Julián Pérez-Beteta
DMD. Molina-García
D. Molina-García
MVM. Villena
M. Villena
MRM.J. Rodríguez
M.J. Rodríguez
Carlos VelasquezCarlos Velasquez
Carlos Velasquez
Víctor M. Pérez-GarcíaVíctor M. Pérez-García
Víctor M. Pérez-García
BACKGROUND AND PURPOSE: Multifocal glioblastomas (ie, glioblastomas with multiple foci, unconnected in postcontrast pretreatment T1-weighted images) represent a challenge in clinical practice due to their poor prognosis. We wished to obtain imaging biomarkers with prognostic value that have not been found previously. MATERIALS AND METHODS: A retrospective review of 1155 patients with glioblastomas from 10 local institutions during 2006–2017 provided 97 patients satisfying the inclusion criteria of the study and classified as having multifocal glioblastomas. Tumors were segmented and morphologic features were computed using different methodologies: 1) measured on the largest focus, 2) aggregating the different foci as a whole, and 3) recording the extreme value obtained for each focus. Kaplan-Meier, Cox proportional hazards, correlations, and Harrell concordance indices (c-indices) were used for the statistical analysis. RESULTS: Age (P < .001, hazard ratio = 2.11, c-index = 0.705), surgery (P < .001, hazard ratio = 2.04, c-index = 0.712), contrast-enhancing rim width (P < .001, hazard ratio = 2.15, c-index = 0.704), and surface regularity (P = .021, hazard ratio = 1.66, c-index = 0.639) measured on the largest focus were significant independent predictors of survival. Maximum contrast-enhancing rim width (P = .002, hazard ratio = 2.05, c-index = 0.668) and minimal surface regularity (P = .036, hazard ratio = 1.64, c-index = 0.600) were also significant. A multivariate model using age, surgery, and contrast-enhancing rim width measured on the largest foci classified multifocal glioblastomas into groups with different outcomes (P < .001, hazard ratio = 3.00, c-index = 0.853, median survival difference = 10.55 months). Moreover, quartiles with the highest and lowest individual prognostic scores based on the focus with the largest volume and surgery were identified as extreme groups in terms of survival (P < .001, hazard ratio = 18.67, c-index = 0.967). CONCLUSIONS: A prognostic model incorporating imaging findings on pretreatment postcontrast T1-weighted MRI classified patients with glioblastoma into different prognostic groups.

24 June 2025 in Neurosurgical Review
Verified
Journal Article
Open access
GUGemma Urbanos
Gemma Urbanos
ACAna M. Castaño-León
Ana M. Castaño-León
MMMónica Maldonado-Luna
Mónica Maldonado-Luna
ESElena Salvador
Elena Salvador
ARAna Ramos-Gonzalez
Ana Ramos-Gonzalez
Alfonso LagaresAlfonso Lagares
Alfonso Lagares
Subarachnoid hemorrhage (SAH) is a severe condition with high morbidity and long-term neurological consequences. Radiomics, by extracting quantitative features from Computed Tomograhpy (CT) scans, may reveal imaging biomarkers predictive of outcomes. This study evaluates the predictive value of radiomics in SAH for multiple outcomes and compares its performance to models based on clinical data.Radiomic features were extracted from admission CTs using segmentations of brain tissue (white and gray matter) and hemorrhage. Machine learning models with cross-validation were trained using clinical data, radiomics, or both, to predict 6-month mortality, Glasgow Outcome Scale (GOS), vasospasm, and long-term hydrocephalus. SHapley Additive exPlanations (SHAP) analysis was used to interpret feature contributions.The training dataset included 403 aneurysmal SAH patients; GOS predictions used all patients, while vasospasm and hydrocephalus predictions excluded those with incomplete data or early death, leaving 328 and 332 patients, respectively. Radiomics and clinical models demonstrated comparable performance, achieving in validation set AUCs more than 85% for six-month mortality and clinical outcome, and 75% and 86% for vasospasm and hydrocephalus, respectively. In an independent cohort of 41 patients, the combined models yielded AUCs of 89% for mortality, 87% for clinical outcome, 66% for vasospasm, and 72% for hydrocephalus. SHAP analysis highlighted significant contributions of radiomic features from brain tissue and hemorrhage segmentation, alongside key clinical variables, in predicting SAH outcomes.This study underscores the potential of radiomics-based approaches for SAH outcome prediction, demonstrating predictive power comparable to traditional clinical models and enhancing understanding of SAH-related complications. Clinical trial number Not applicable.

12 January 2023 in Neuroradiology
Verified
Journal Article
Closed access
PDF file
PPPaul Martin Putora
Paul Martin Putora
GAGonçalo G. Almeida
Gonçalo G. Almeida
SWSimon Wildermuth
Simon Wildermuth
JWJohannes Weber
Johannes Weber
TDTobias Johannes Dietrich
Tobias Johannes Dietrich
TFTim Fischer
Tim Fischer

7 April 2024 in European Radiology
Verified
Journal Article
Closed access
PDF file
ARAna Ramos-Gonzalez
Ana Ramos-Gonzalez
AHAmaya Hilario
Amaya Hilario

20 August 2026 in Neuro-Oncology
Verified
Journal Article
Closed access
LLLieselotte Lauwens
Lieselotte Lauwens
CZCatharina M.L. Zegers
Catharina M.L. Zegers
APAlida Annechien Postma
Alida Annechien Postma
Giuseppe MinnitiGiuseppe Minniti
Giuseppe Minniti
CAClaire Alapetite
Claire Alapetite
DEDaniëlle Berty Petra Eekers
Daniëlle Berty Petra Eekers
Magnetic resonance imaging (MRI) is essential for post-treatment surveillance of patients with intracranial central nervous system (CNS) tumors. However, interpretation is often complicated due to post radiotherapy MRI abnormalities. Current literature demonstrates substantial heterogeneity in terminology and definitions used to describe these MRI abnormalities, limiting clinical decision-making and comparability across studies. To address this, an international multidisciplinary Delphi consensus was conducted within the Radiation Imaging and Neuro-Oncology Group (RING). Questionnaires were developed by the steering committee and distributed to experts in radiation oncology, neuroradiology, neuro-oncology, medical oncology, and neurosurgery. A three-round Delphi method was employed, with consensus defined as ≥75% agreement. Consensus was reached on the applicability and definitions with adoption of the term Treatment-Related Imaging Abnormality (TRIA). Clear definitions for potential and confirmed TRIA were established. Subcategorization based on imaging features all demonstrated high agreement. For consistent application of the framework minimal essential elements for MRI request forms were identified. The final consensus was endorsed by ESTRO, ESNR and EORTC. This Delphi consensus provides a standardized framework for MRI abnormalities following radiotherapy for intracranial CNS tumors. The framework aims to harmonize reporting, support clinical decision-making, and improve comparability in future neuro-oncology research.